Comparison Centessa Pharmaceuticals (CNTA) with Competitors
Centessa Pharmaceuticals (CNTA) industry is Biotechnology.
Debt-to-Equity
CNTA22.66%
Industry28.27%
Upside-19.83%
Free Cash Flow Yield
CNTA-3.34%
Industry-1.75%
Upside-1.59%
P/E
CNTA-23.28
Industry-20.52
Upside-276.15%